Back to search

Article

Aβ-Overlapping Ectodomain Binding of the Clinical-Stage TREM2 Agonist VG-3927

2026-03-05

Abstract excerpt

Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial immune receptor genetically and functionally linked to Alzheimer’s disease (AD). VG-3927, the first clinical-stage small-molecule TREM2 agonist, has been proposed to function as a transmembrane molecular glue and positive allosteric modulator (PAM). Whether it directly engages the extracellular ligand-recognition surface of TREM2 remains unkn...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
98255c54-512a-5eba-b841-69a4169fc1eb
DOI
10.64898/2026.03.02.709194
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Aβ-Overlapping Ectodomain Binding of the Clinical-Stage TREM2 Agonist VG-3927DOI 10.64898/2026.03.02.709194
Select a neighboring publication to make it the new centre.